The scrip opened at Rs 2945.15 and touched an intraday high and low of Rs 2977.0 and Rs 2941.55, respectively, in the session so far. Shares of the company of Torrent Pharmaceuticals Ltd. quoted a 52-week high of Rs 3040.0 and a 52-week low of Rs 2232.0.
As per BSE, the total market cap of the Torrent Pharmaceuticals Ltd. stood at Rs 49887.7 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 1976.0 crore for the quarter ended 31-Mar-2021, down 1.35 per cent from previous quarter’s Rs 2003.0 crore and down 0.76 per cent from the year-ago quarter’s Rs 1961.0 crore.
The net profit for latest quarter stood at Rs 324.0 crore, up 3.18 per cent from the corresponding quarter last year.
Shareholding pattern
As of 31-Mar-2021, domestic institutional investors held 6.47 per cent stake in the firm, while foreign institutional investors held 11.37 per cent and the promoters 71.25 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 39.85 and a price-to-book ratio of 7.37. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Torrent Pharmaceuticals Ltd. belongs to the Pharma – Indian industry.
